ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance

ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistanceATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance, Published online: 20 February 2019; doi:10.1038/s41419-019-1362-2ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance

Source: Cell death and disease - February 20, 2019 Category: Internal Medicine Authors: Li Lin Xiaoyin Li Changqie Pan Wanying Lin Ruoyang Shao Yantan Liu Junhao Zhang Yuhao Luo Kai Qian Min Shi Jianping Bin Yulin Liao Wangjun Liao Source Type: research